CA3195404A1 - Procede et appareil de test de perte de la vision des couleurs - Google Patents
Procede et appareil de test de perte de la vision des couleursInfo
- Publication number
- CA3195404A1 CA3195404A1 CA3195404A CA3195404A CA3195404A1 CA 3195404 A1 CA3195404 A1 CA 3195404A1 CA 3195404 A CA3195404 A CA 3195404A CA 3195404 A CA3195404 A CA 3195404A CA 3195404 A1 CA3195404 A1 CA 3195404A1
- Authority
- CA
- Canada
- Prior art keywords
- color
- patient
- contrast
- testing
- cone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 478
- 238000000034 method Methods 0.000 title claims abstract description 120
- 230000004456 color vision Effects 0.000 title claims abstract description 51
- 201000004569 Blindness Diseases 0.000 title description 8
- 230000035945 sensitivity Effects 0.000 claims abstract description 47
- 230000004044 response Effects 0.000 claims description 153
- 230000003247 decreasing effect Effects 0.000 claims description 28
- 239000003086 colorant Substances 0.000 claims description 23
- 201000010099 disease Diseases 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
- 238000004891 communication Methods 0.000 claims description 14
- 230000002123 temporal effect Effects 0.000 claims description 11
- 238000003860 storage Methods 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 description 53
- 230000008569 process Effects 0.000 description 36
- 230000004424 eye movement Effects 0.000 description 32
- 230000007812 deficiency Effects 0.000 description 20
- 230000004304 visual acuity Effects 0.000 description 18
- 230000004438 eyesight Effects 0.000 description 16
- 238000012956 testing procedure Methods 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 238000012216 screening Methods 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 238000012790 confirmation Methods 0.000 description 9
- 230000004315 low visual acuity Effects 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 231100000419 toxicity Toxicity 0.000 description 9
- 230000001988 toxicity Effects 0.000 description 9
- 230000000007 visual effect Effects 0.000 description 9
- 206010047531 Visual acuity reduced Diseases 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 230000001755 vocal effect Effects 0.000 description 7
- 208000012902 Nervous system disease Diseases 0.000 description 6
- 208000025966 Neurological disease Diseases 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 206010048955 Retinal toxicity Diseases 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 208000030533 eye disease Diseases 0.000 description 5
- 230000008447 perception Effects 0.000 description 5
- 231100000385 retinal toxicity Toxicity 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000003190 augmentative effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 230000004393 visual impairment Effects 0.000 description 4
- 206010061818 Disease progression Diseases 0.000 description 3
- 208000010412 Glaucoma Diseases 0.000 description 3
- 208000017442 Retinal disease Diseases 0.000 description 3
- 230000001149 cognitive effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 230000005750 disease progression Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 231100000040 eye damage Toxicity 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 208000006992 Color Vision Defects Diseases 0.000 description 2
- 208000036693 Color-vision disease Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000010415 Low Vision Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 208000018769 loss of vision Diseases 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- 230000004303 low vision Effects 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000004483 macular pigment optical density Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 210000000608 photoreceptor cell Anatomy 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/02—Subjective types, i.e. testing apparatus requiring the active assistance of the patient
- A61B3/028—Subjective types, i.e. testing apparatus requiring the active assistance of the patient for testing visual acuity; for determination of refraction, e.g. phoropters
- A61B3/032—Devices for presenting test symbols or characters, e.g. test chart projectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/02—Subjective types, i.e. testing apparatus requiring the active assistance of the patient
- A61B3/06—Subjective types, i.e. testing apparatus requiring the active assistance of the patient for testing light sensitivity, e.g. adaptation; for testing colour vision
- A61B3/066—Subjective types, i.e. testing apparatus requiring the active assistance of the patient for testing light sensitivity, e.g. adaptation; for testing colour vision for testing colour vision
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/113—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining or recording eye movement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/18—Arrangement of plural eye-testing or -examining apparatus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Human Computer Interaction (AREA)
- Eye Examination Apparatus (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
Procédé d'administration d'un test de la vision des couleurs à contraste des cônes consistant à afficher une première couleur à un premier niveau de contraste dans une première région d'un écran et une seconde couleur à un premier niveau de contraste dans une deuxième région de l'écran, à recevoir un premier signal d'entrée par l'intermédiaire d'un dispositif d'entrée qui indique si le patient reconnaît la première région, à afficher la première couleur à un second niveau de contraste dans une troisième région de l'écran et la seconde couleur à un second niveau de contraste dans une quatrième région de l'écran, à recevoir un second signal d'entrée indiquant si le patient reconnaît la troisième région, à attribuer un score lié à la sensibilité des cônes à la première couleur au niveau des premier et second niveaux de contraste, à stocker le score, et à comparer le score à un score antérieur pour calculer une progression d'une perte de sensibilité des cônes.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/068,417 | 2020-10-12 | ||
| US17/068,417 US11883097B2 (en) | 2012-05-03 | 2020-10-12 | Method and apparatus for testing for color vision loss |
| US202163262416P | 2021-10-12 | 2021-10-12 | |
| US63/262,416 | 2021-10-12 | ||
| PCT/US2021/071824 WO2022082171A1 (fr) | 2020-10-12 | 2021-10-12 | Procédé et appareil de test de perte de la vision des couleurs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3195404A1 true CA3195404A1 (fr) | 2022-04-21 |
Family
ID=81209435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3195404A Pending CA3195404A1 (fr) | 2020-10-12 | 2021-10-12 | Procede et appareil de test de perte de la vision des couleurs |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2023546171A (fr) |
| CA (1) | CA3195404A1 (fr) |
| WO (1) | WO2022082171A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240188818A1 (en) * | 2022-12-08 | 2024-06-13 | Twenty Twenty Therapeutics Llc | Eye tracking color vision tests |
| CN115868919A (zh) * | 2022-12-08 | 2023-03-31 | 合肥全色光显科技有限公司 | 一种基于人眼的色域测量方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013166473A1 (fr) * | 2012-05-03 | 2013-11-07 | Nordstrom Cheryl | Procédé et appareil pour tester la perte de la vision des couleurs |
| WO2013170091A1 (fr) * | 2012-05-09 | 2013-11-14 | The Schepens Eye Research Institute, Inc. | Mesure rapide de sensibilité visuelle |
| US10561312B2 (en) * | 2014-05-02 | 2020-02-18 | Cheryl Nordstrom | Method and apparatus for administering a low luminance visual dysfunction test |
| JP6184046B1 (ja) * | 2017-06-09 | 2017-08-23 | 株式会社中京メディカル | 検査装置及び検査方法 |
-
2021
- 2021-10-12 CA CA3195404A patent/CA3195404A1/fr active Pending
- 2021-10-12 JP JP2023523596A patent/JP2023546171A/ja active Pending
- 2021-10-12 WO PCT/US2021/071824 patent/WO2022082171A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022082171A1 (fr) | 2022-04-21 |
| JP2023546171A (ja) | 2023-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12161410B2 (en) | Systems and methods for vision assessment | |
| US10849491B2 (en) | Method and device for determining the visual acuity of a user | |
| US11883097B2 (en) | Method and apparatus for testing for color vision loss | |
| US9883794B1 (en) | Method and apparatus for testing for color vision loss | |
| Brozinsky et al. | Motion velocity thresholds in deaf signers: changes in lateralization but not in overall sensitivity | |
| US20080013047A1 (en) | Diagnostic and Therapeutic System for Eccentric Viewing | |
| US20220160223A1 (en) | Methods and Systems for Evaluating Vision Acuity and/or Conducting Visual Field Tests in a Head-Mounted Vision Device | |
| AU2016410178A1 (en) | Method and system for quantitative assessment of visual motor response | |
| CA3195404A1 (fr) | Procede et appareil de test de perte de la vision des couleurs | |
| US12148321B2 (en) | Device and method for providing visual ability training using visual perceptual learning | |
| US12453468B2 (en) | Method and apparatus for testing for color vision loss | |
| EP4225126A1 (fr) | Procédé et appareil de test de perte de la vision des couleurs | |
| US10799108B1 (en) | Method and apparatus for testing for color vision loss | |
| WO2022115860A1 (fr) | Procédés et systèmes pour évaluer l'acuité visuelle et/ou effectuer des tests de champ visuel dans un dispositif de vision monté sur la tête | |
| TWI796222B (zh) | 以沉浸式虛擬實境設備評估具視覺空間特異性之反應時間評估系統與方法 | |
| US20250194987A1 (en) | System and a method for determining a health condition of a subject | |
| GB2623790A (en) | Systems and methods for assessing visuo-cognitive function | |
| Balodis et al. | Development of Visual Test Software in Mobile Diagnostic System. |